The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study
Background A recent trial showed that postmenopausal women diagnosed with hormone
receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative, lymph node …
receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative, lymph node …
The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective
V Berdunov, E Laws, G Cuyun Carter… - Journal of Medical …, 2023 - Taylor & Francis
Abstract Background and objectives The Oncotype DX Breast Recurrence Score test is used
to estimate distant recurrence risk of hormone receptor-positive (HR+) and human epidermal …
to estimate distant recurrence risk of hormone receptor-positive (HR+) and human epidermal …